Education
About Us
Working with TipRanks
Follow Us
Cormedix Inc. (CRMD)
:CRMD
Total Valuation
Cormedix has a market cap or net worth of $1.04B. The enterprise value is $695.76M.
Market Cap$1.04B
Enterprise Value$695.76M
Share Statistics
Cormedix has 74,648,994 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding74,648,994
Owned by Insiders2.01%
Owned by Institutions10.16%
Financial Efficiency
Cormedix’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -24.35%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-24.35%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee679.25K
Profits Per Employee-280.16K
Employee Count64
Asset Turnover0.37
Inventory Turnover0.42
Valuation Ratios
The current PE Ratio of Cormedix is 18.7. Cormedix’s PEG ratio is ―.
PE Ratio18.7
PS Ratio―
PB Ratio―
Price to Fair Value5.63
Price to FCF―
Price to Operating Cash Flow26.94
PEG Ratio―
Income Statement
In the last 12 months, Cormedix had revenue of 43.47M and earned -17.93M in profits. Earnings per share was -0.30.
Revenue43.47M
Gross Profit40.28M
Operating Income-22.36M
Pretax Income-19.32M
Net Income-17.93M
EBITDA-18.83M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was 30.46M and capital expenditures -19.64K, giving a free cash flow of 49.71B billion.
Operating Cash Flow30.46M
Free Cash Flow49.71B
Free Cash Flow per Share665.90
Dividends & Yields
Cormedix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.70
52-Week Price Change130.48%
50-Day Moving Average12.33
200-Day Moving Average10.75
Relative Strength Index (RSI)68.70
Average Volume (3m)2.98M
Important Dates
Cormedix upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Cormedix as a current ratio of 3.39, with Debt / Equity ratio of <0.01%
Current Ratio3.39
Quick Ratio3.16
Debt to Market Cap0.00
Net Debt to EBITDA2.13
Interest Coverage Ratio-614.10
Taxes
In the past 12 months, Cormedix has paid -1.39M in taxes.
Income Tax-1.39M
Effective Tax Rate0.07
Enterprise Valuation
Cormedix EV to EBITDA ratio is -23.19, with an EV/FCF ratio of -8.61.
EV to Sales10.05
EV to EBITDA-23.19
EV to Free Cash Flow-8.61
EV to Operating Cash Flow-8.63
Balance Sheet
Cormedix has $190.71B in cash and marketable securities with $435.25K in debt, giving a net cash position of -$190.71B billion.
Cash & Marketable Securities$190.71B
Total Debt$435.25K
Net Cash-$190.71B
Net Cash Per Share-$2.55K
Tangible Book Value Per Share$1.41
Margins
Gross margin is 95.62%, with operating margin of -51.43%, and net profit margin of -41.24%.
Gross Margin95.62%
Operating Margin-51.43%
Pretax Margin-44.45%
Net Profit Margin-41.24%
EBITDA Margin-43.32%
EBIT Margin-44.37%
Analyst Forecast
The average price target for Cormedix is $19.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$19.50
Price Target Upside39.39% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast14970.29%
EPS Growth Forecast―